Public Health is a multidisciplinary field that focuses on promoting and protecting the health of entire populations through disease prevention, health promotion, and health equity. Vaccines play a crucial role in public health efforts by preventing infectious diseases, reducing the burden of illness and death, and promoting community immunity.
One of the primary goals of public health is to prevent the spread of infectious diseases through vaccination programs. By immunizing large segments of the population against common pathogens, such as measles, influenza, and polio, public health authorities can reduce the incidence of disease outbreaks and prevent the spread of infectious agents within communities.
Vaccination programs are typically implemented through national or regional immunization schedules, which recommend the timing and doses of vaccines for different age groups and populations. These schedules are based on scientific evidence, epidemiological data, and public health priorities, and are regularly updated to reflect changes in disease prevalence, vaccine effectiveness, and emerging infectious threats.
In addition to preventing infectious diseases, vaccines also offer other benefits to public health. They can reduce healthcare costs by preventing expensive medical treatments and hospitalizations associated with vaccine-preventable diseases. They also help to protect vulnerable populations, such as infants, elderly individuals, and those with weakened immune systems, who may be at higher risk of complications from infectious diseases. Public health authorities play a critical role in promoting vaccination as a safe, effective, and essential component of preventive medicine. They work to educate the public about the importance of vaccination, address concerns and misconceptions about vaccines, and ensure equitable access to vaccines for all populations.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States
Title : Hypersensitivity and anti-SARS-COV-2 vaccination: A retrospective study of the year 2021 at the University Hospital Center of Tours (France)
Faure Quentin, The Savoie Metropolitan Hospital Center, France
Title : THE HPV vaccination program in Colombia. From a beautiful dream to a nightmare, but hopefully with a bright dawn.
Carlos Castro, Colombian League against cancer, Colombia